Pharmaceutical Executive

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis trials. She also talks about Takeda's partnerships with community stakeholders like Inside Edge, Black Health Matters, and Hispanic Communication Global Network to help improve engagement, address operational barriers by incorporating multicultural imagery, and prioritize sites with diverse patient demographics. She also explains how they've enhanced investigator diversity through educational sessions and multilingual toolkits, and how Takeda aims to expand these efforts globally.

In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses: *  The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications * How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts.  * How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts *  The importance of telehealth in ensuring medication availability * Strategic partnerships between digital health platforms and pharma companies to improve patient care and access * and more

In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses: * The threat of misinformation to public health and how emotional appeal plays a part * Where patients are turning for trustworthy health information * Strategies that can be used to verify information * Pharma's role in helping to ensure patients have access to health insights they can trust * Why the industry is turning to peer-to-patient platforms,  trusted patient communities, and pharmacies to educate patients * What kind of role regulatory agencies should play in the battle against misinformation * and much more! Check out our new look and read our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025 [https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025]

In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss: *  The growing distrust in social media * Why people trust friends and influencers over companies * The EMA's departure from X  * Concerns about information accessibility * The healthcare industry's trust gap  * "Dark Social" * and SO MUCH MORE! Pharmaceutical Executive has a brand new look! Click through our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025 [https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025]

In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence. By utilizing patient-level data and predictive modeling, AI can identify individual needs and preferences, tailoring interventions to optimize treatment outcomes. This personalized approach addresses the common challenges of medication non-adherence and improves patient outcomes. The discussion highlights the importance of ethical considerations and data privacy when leveraging AI in healthcare. By focusing on patient well-being and using AI responsibly, healthcare providers can significantly enhance patient experiences and improve overall health outcomes.